Pure Global
NCT05604768

Study on Initiation and Immunological Mechanism of Childbirth

Study on the Initiation and Immunological Mechanism of Parturition
Beijing Ditan Hospital·ClinicalTrials.govRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Pregnancy
Study type
Observational
Sponsor & location
Primary sponsor
Beijing Ditan Hospital
Location
Beijing, China
Timeline & enrollment
Phase
N/A
Start date
Mar 28, 2022
End date
Mar 28, 2025
Enrollment
40 participants
Primary outcome

The change of the frequency of myeloid-derived suppressor cells (MDSCs) in normal pregnancy and delivery,The change of functional molecules expression of myeloid-derived suppressor cells (MDSCs) in normal pregnancy and delivery,The change of the frequency of plasmacytoid dendritic cells (pDC) in normal pregnancy and delivery,The change of the functional molecules expression of plasmacytoid dendritic cells (pDC) in normal pregnancy and delivery,The change of the frequency of Nature Killer (NK) cells in normal pregnancy and delivery,The change of the functional molecules expression of Nature Killer (NK) cells in normal pregnancy and delivery,The change of the content of cffDNA in normal pregnancy and delivery

Summary

This study is a prospective observational study. The participants including 40 pregnant women
 who have been filed and delivered in our hospital will enrolled, collect venous blood will be
 collected at different stages of pregnancy, delivery, postpartum to detect the concentration
 of fetal free DNA, the frequency of associated immune cells, and the expression of functional
 molecules, so as to explore the immunological mechanism of delivery initiation.

ICD-10 classifications
Pregnancy confirmedPregnancy-related condition, unspecifiedAbdominal pregnancyPregnancy, not (yet) confirmedOvarian pregnancy
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05604768
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05604768 through Pure Global AI's free database. This phase not specified trial is sponsored by Beijing Ditan Hospital and is currently Recruiting. The study focuses on Pregnancy. Target enrollment is 40 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.